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Animal-assisted therapy is a growth industry. According to a survey conducted by the Human Animal
Bond Research Initiative, 69% of family practice physicians have worked with animals in medical
settings. And Yale researchers reported that when it comes to the treatment of children with behavior
problems, the public views animal-based therapies about as acceptable as psychotherapy and much
more acceptable than drug treatments.
These interventions are attracting the attention of a growing number of investigators. The graph below
shows the number of research articles published on animal-assisted therapies between 1990 and 2015.
Research in this area is increasing at an exponential rate, with the number of published papers doubling
every 3.6 years. That’s the good news.
What We Can Learn from Studies of “The Love Hormone”
The bad news is that most studies of the effectiveness of therapies using creatures like dogs, horses, and
dolphins are flawed. Among the most common problems are inadequate control groups, lack of long-term
follow-ups, insufficient controls for researcher expectations, and no standardized treatment
procedures. But here I want to focus on the fact that most animal therapy studies do not have enough
subjects to produce valid results.

I became aware of the “sample size problem” when I came across a surprising headline in the magazine
New Scientist—"Everything You’ve Heard About Sniffing Oxytocin Might Be Wrong." Oxytocin, of
course, is the neurochemical often referred to as the “love hormone.” Over 1,000 studies have linked
oxytocin to a host of behaviors, including maternal care, trust, sexual responses, and even our
connections to pets. The author of the New Scientist article, Simon Oxenham, described a series of
publications which have called these results into question. A 2015 paper, for example, reported that many
studies showing that oxytocin increases trust have not been replicated by other researchers.
And, like other areas of science, oxytocin studies are prone to “the file drawer effect”—a bias against
publishing negative results. This issue was brought home by a group of researchers in Belgium. Stung by
the failure to replicate one of their own studies, they dug back into their file drawer for failed experiments.
They were shocked to find that 24 out of 25 of their previous studies found oxytocin had little or no impact
on the behaviors they were interested in.
The Love Hormone's Sample Size Problem
According to the Belgian researchers, one reason oxytocin studies are often unreliable is there are too
few subjects in the experiments. Hasse Walum of Emory University and his colleagues Irwin Waldman
and Larry Young did the math and, in a paper recently published in the journal Biological Psychiatry,
reported the Belgians were right. To understand their analysis, you need to know a couple of basic
statistical concepts (bear with me for a minute—this is not rocket science).
The Effect Size of a study is an index of the magnitude of the differences obtained between the treatment
group in an experiment and the control group. It is usually reported as “Cohen’s d.” The higher d is, the
bigger the impact of the treatment. If d is .20, the treatment is said to have had little impact; a d of around
.50 or so is regarded as indicating a medium size impact, and a d of .80 or greater signifies a large
treatment effect.
The Statistical Power of a study is the likelihood it has enough subjects to detect the impact of treatment
condition…if there really is one. In most studies, researchers aim for a statistical power of .80. This
means you have enough subjects so that 80% of the time, your experiment would uncover true
effects. While statistical power is affected by the number of subjects, it is also influenced by the effect
size. If a treatment effect is small, you need more subjects to detect it. Studies with too few subjects are
said to be “underpowered.” Paradoxically, underpowered research is both more likely to miss real effects
and also to obtain positive results that later turn out to be false. The reason is that these studies tend to
overestimate effect sizes when they are found.
Walum’s group examined the statistical power of a set of experiments which examined the impact of
sniffing oxytocin on human behavior. Together, these studies involved 57 comparisons between a
treatment group and a control group. The average effect size in these comparisons was .28, which is on
the small side. The studies included, on average, 49 subjects. Walum calculated that the average
statistical power of these studies was only 16%. These findings suggests that at least 84% of the
time, the oxytocin experiments produced incorrect results even if a true effect of
the hormone really exists.
Animal-Assisted Therapy Studies Have the Same Problem
Intrigued, I contacted Hasse to see if his analysis could be applied to animal-assisted therapy studies. He
said yes, so I sent him some numbers. To estimate the sample size of the typical study, I used the trials
described in 10 research reviews. The median sample size of these studies was 24.5 subjects. To
estimate the effect size of animal therapy clinical trials I turned to a meta-analysis of 49 studies by Janelle

Nimer and Brad Lundahl. The average effect size among these trials was .46. Plugging in these numbers,
I was surprised to find that the statistical power of the animal-assisted therapy studies was only about
20%—way short of the desired 80% mark.

Here is the bottom line. Most research on the effectiveness of animal assisted therapy is seriously
underpowered. As a result, the majority of studies on the use of animals as therapists either do not
detect a real therapeutic impact of or obtain false or inflated positive results. The obvious question
is, how many subjects would it take to get to a statistical power of 80%? The magic number is 152. Only a
handful of the hundreds of animal therapy studies have nearly this many subjects.
I admit these findings are depressing. But, while it is of little consolation, things are even worse in other
areas. For example, the average statistical power of brain imaging research is only 8%. This means that
the conclusions drawn from these studies are likely to be wrong 90% of the time.
Based on their analysis of the number of subjects in oxytocin studies, Walum and his colleagues wrote,
“There is a high probability that most of the published intranasal oxytocin findings do not represent true
effect.”
Is this also true for the results of animal-assisted therapy studies?
Thanks to Hasse Walum for his comments on this post.
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